Josh Sullivan – Endpoints News

about the author

Josh Sullivan

josh@endpointsnews.com

author articles

SQZ's outside-the-box manufacturing method slashes production time early in study

3 years ago

Catalent introduces new AAV gene therapy tech in aim to speed up manufacturing process

3 years ago

With new acquisition, Bora to venture into biologics

3 years ago

Long-expected UK layoffs imminent for Novartis following sale

3 years ago

Emergent inks $225M cash smallpox deal as Chimerix implodes on reorg, FDA trouble

4 years ago

UK generics maker shutters, eliminating 1,000 jobs

4 years ago

After ramping up its vaccine production in South Africa, Aspen yet to receive a single order

4 years ago

PCI further expands into New England with fill-finish upgrade in New Hampshire

4 years ago

Q&A: Through robotics, Fred Parietti and team look to fix cell therapy's future

4 years ago

Brigham and Women's gets FDA warning letter after PET operation violations

4 years ago

Cytiva's latest project to open in Switzerland at the end of the month

4 years ago

Sun Pharma site hit with second Form 483 in 3 years

4 years ago

Emergent tossed nearly 400M Covid-19 vaccine doses in Baltimore debacle, House report says

4 years ago

Homegrown mRNA Thai vaccine for Covid-19 could be ready by year end — report

4 years ago

Ex-Sanofi CEO on board, a new $158M SPAC debuts looking to shake up the European CDMO market

4 years ago

Consortium to automate cell therapy manufacturing welcomes Thermo Fisher and Charles River Labs

4 years ago

Two Novartis sites stop manufacturing cancer therapies after quality issues

4 years ago

FDA to create training program to inspect more mRNA vaccine manufacturing

4 years ago

Societal nabs sole supplier role for Ritalin to Europe

4 years ago

Matica's cell & gene therapy site up and running in Texas

4 years ago

Novotech extends arms into US with acquisition of a South Carolina CRO

4 years ago

Incyte changes manufacturing process, adds second site to solve Opzelura texture issue

4 years ago

Two investors team up for CordenPharma buyout following mRNA vaccine success

4 years ago

Supernus' nonstimulant ADHD drug Qelbree gains approval for adult use

4 years ago

12 3 4 Next page Last page